Global Oral Voriconazole Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Oral Voriconazole Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Voriconazole Tablets
  • 1.2.3 Voriconazole Capsules
  • 1.2.4 Voriconazole Suspension
• 1.3 Market by Application
  • 1.3.1 Global Oral Voriconazole Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Hospital Pharmacy
  • 1.3.3 Retail Pharmacy
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Oral Voriconazole Market Perspective (2019-2030)
• 2.2 Global Oral Voriconazole Growth Trends by Region
  • 2.2.1 Global Oral Voriconazole Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Oral Voriconazole Historic Market Size by Region (2019-2024)
  • 2.2.3 Oral Voriconazole Forecasted Market Size by Region (2025-2030)
• 2.3 Oral Voriconazole Market Dynamics
  • 2.3.1 Oral Voriconazole Industry Trends
  • 2.3.2 Oral Voriconazole Market Drivers
  • 2.3.3 Oral Voriconazole Market Challenges
  • 2.3.4 Oral Voriconazole Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Oral Voriconazole by Players
  • 3.1.1 Global Oral Voriconazole Revenue by Players (2019-2024)
  • 3.1.2 Global Oral Voriconazole Revenue Market Share by Players (2019-2024)
• 3.2 Global Oral Voriconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Oral Voriconazole, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Oral Voriconazole Market Concentration Ratio
  • 3.4.1 Global Oral Voriconazole Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Oral Voriconazole Revenue in 2023
• 3.5 Global Key Players of Oral Voriconazole Head office and Area Served
• 3.6 Global Key Players of Oral Voriconazole, Product and Application
• 3.7 Global Key Players of Oral Voriconazole, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Voriconazole Breakdown Data by Type

• 4.1 Global Oral Voriconazole Historic Market Size by Type (2019-2024)
• 4.2 Global Oral Voriconazole Forecasted Market Size by Type (2025-2030)

5 Oral Voriconazole Breakdown Data by Application

• 5.1 Global Oral Voriconazole Historic Market Size by Application (2019-2024)
• 5.2 Global Oral Voriconazole Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Oral Voriconazole Market Size (2019-2030)
• 6.2 North America Oral Voriconazole Market Size by Type
  • 6.2.1 North America Oral Voriconazole Market Size by Type (2019-2024)
  • 6.2.2 North America Oral Voriconazole Market Size by Type (2025-2030)
  • 6.2.3 North America Oral Voriconazole Market Share by Type (2019-2030)
• 6.3 North America Oral Voriconazole Market Size by Application
  • 6.3.1 North America Oral Voriconazole Market Size by Application (2019-2024)
  • 6.3.2 North America Oral Voriconazole Market Size by Application (2025-2030)
  • 6.3.3 North America Oral Voriconazole Market Share by Application (2019-2030)
• 6.4 North America Oral Voriconazole Market Size by Country
  • 6.4.1 North America Oral Voriconazole Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Oral Voriconazole Market Size by Country (2019-2024)
  • 6.4.3 North America Oral Voriconazole Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Oral Voriconazole Market Size (2019-2030)
• 7.2 Europe Oral Voriconazole Market Size by Type
  • 7.2.1 Europe Oral Voriconazole Market Size by Type (2019-2024)
  • 7.2.2 Europe Oral Voriconazole Market Size by Type (2025-2030)
  • 7.2.3 Europe Oral Voriconazole Market Share by Type (2019-2030)
• 7.3 Europe Oral Voriconazole Market Size by Application
  • 7.3.1 Europe Oral Voriconazole Market Size by Application (2019-2024)
  • 7.3.2 Europe Oral Voriconazole Market Size by Application (2025-2030)
  • 7.3.3 Europe Oral Voriconazole Market Share by Application (2019-2030)
• 7.4 Europe Oral Voriconazole Market Size by Country
  • 7.4.1 Europe Oral Voriconazole Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Oral Voriconazole Market Size by Country (2019-2024)
  • 7.4.3 Europe Oral Voriconazole Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Oral Voriconazole Market Size (2019-2030)
• 8.2 China Oral Voriconazole Market Size by Type
  • 8.2.1 China Oral Voriconazole Market Size by Type (2019-2024)
  • 8.2.2 China Oral Voriconazole Market Size by Type (2025-2030)
  • 8.2.3 China Oral Voriconazole Market Share by Type (2019-2030)
• 8.3 China Oral Voriconazole Market Size by Application
  • 8.3.1 China Oral Voriconazole Market Size by Application (2019-2024)
  • 8.3.2 China Oral Voriconazole Market Size by Application (2025-2030)
  • 8.3.3 China Oral Voriconazole Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Oral Voriconazole Market Size (2019-2030)
• 9.2 Asia Oral Voriconazole Market Size by Type
  • 9.2.1 Asia Oral Voriconazole Market Size by Type (2019-2024)
  • 9.2.2 Asia Oral Voriconazole Market Size by Type (2025-2030)
  • 9.2.3 Asia Oral Voriconazole Market Share by Type (2019-2030)
• 9.3 Asia Oral Voriconazole Market Size by Application
  • 9.3.1 Asia Oral Voriconazole Market Size by Application (2019-2024)
  • 9.3.2 Asia Oral Voriconazole Market Size by Application (2025-2030)
  • 9.3.3 Asia Oral Voriconazole Market Share by Application (2019-2030)
• 9.4 Asia Oral Voriconazole Market Size by Region
  • 9.4.1 Asia Oral Voriconazole Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Oral Voriconazole Market Size by Region (2019-2024)
  • 9.4.3 Asia Oral Voriconazole Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Oral Voriconazole Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Oral Voriconazole Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Oral Voriconazole Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Oral Voriconazole Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Pfizer Business Overview
  • 11.1.3 Pfizer Oral Voriconazole Introduction
  • 11.1.4 Pfizer Revenue in Oral Voriconazole Business (2019-2024)
  • 11.1.5 Pfizer Recent Development
• 11.2 Sandoz
  • 11.2.1 Sandoz Company Details
  • 11.2.2 Sandoz Business Overview
  • 11.2.3 Sandoz Oral Voriconazole Introduction
  • 11.2.4 Sandoz Revenue in Oral Voriconazole Business (2019-2024)
  • 11.2.5 Sandoz Recent Development
• 11.3 Sun Pharmaceutical
  • 11.3.1 Sun Pharmaceutical Company Details
  • 11.3.2 Sun Pharmaceutical Business Overview
  • 11.3.3 Sun Pharmaceutical Oral Voriconazole Introduction
  • 11.3.4 Sun Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024)
  • 11.3.5 Sun Pharmaceutical Recent Development
• 11.4 Teva
  • 11.4.1 Teva Company Details
  • 11.4.2 Teva Business Overview
  • 11.4.3 Teva Oral Voriconazole Introduction
  • 11.4.4 Teva Revenue in Oral Voriconazole Business (2019-2024)
  • 11.4.5 Teva Recent Development
• 11.5 Taj Pharmaceuticals
  • 11.5.1 Taj Pharmaceuticals Company Details
  • 11.5.2 Taj Pharmaceuticals Business Overview
  • 11.5.3 Taj Pharmaceuticals Oral Voriconazole Introduction
  • 11.5.4 Taj Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024)
  • 11.5.5 Taj Pharmaceuticals Recent Development
• 11.6 SiNi Pharma
  • 11.6.1 SiNi Pharma Company Details
  • 11.6.2 SiNi Pharma Business Overview
  • 11.6.3 SiNi Pharma Oral Voriconazole Introduction
  • 11.6.4 SiNi Pharma Revenue in Oral Voriconazole Business (2019-2024)
  • 11.6.5 SiNi Pharma Recent Development
• 11.7 Lupin Pharmaceuticals
  • 11.7.1 Lupin Pharmaceuticals Company Details
  • 11.7.2 Lupin Pharmaceuticals Business Overview
  • 11.7.3 Lupin Pharmaceuticals Oral Voriconazole Introduction
  • 11.7.4 Lupin Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024)
  • 11.7.5 Lupin Pharmaceuticals Recent Development
• 11.8 Viona Pharmaceuticals
  • 11.8.1 Viona Pharmaceuticals Company Details
  • 11.8.2 Viona Pharmaceuticals Business Overview
  • 11.8.3 Viona Pharmaceuticals Oral Voriconazole Introduction
  • 11.8.4 Viona Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024)
  • 11.8.5 Viona Pharmaceuticals Recent Development
• 11.9 Yangzijiang Pharmaceutical Group
  • 11.9.1 Yangzijiang Pharmaceutical Group Company Details
  • 11.9.2 Yangzijiang Pharmaceutical Group Business Overview
  • 11.9.3 Yangzijiang Pharmaceutical Group Oral Voriconazole Introduction
  • 11.9.4 Yangzijiang Pharmaceutical Group Revenue in Oral Voriconazole Business (2019-2024)
  • 11.9.5 Yangzijiang Pharmaceutical Group Recent Development
• 11.10 Huahai Pharmaceutical
  • 11.10.1 Huahai Pharmaceutical Company Details
  • 11.10.2 Huahai Pharmaceutical Business Overview
  • 11.10.3 Huahai Pharmaceutical Oral Voriconazole Introduction
  • 11.10.4 Huahai Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024)
  • 11.10.5 Huahai Pharmaceutical Recent Development
• 11.11 Beijing Genetech Pharmaceutical
  • 11.11.1 Beijing Genetech Pharmaceutical Company Details
  • 11.11.2 Beijing Genetech Pharmaceutical Business Overview
  • 11.11.3 Beijing Genetech Pharmaceutical Oral Voriconazole Introduction
  • 11.11.4 Beijing Genetech Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024)
  • 11.11.5 Beijing Genetech Pharmaceutical Recent Development
• 11.12 Union-Bio science
  • 11.12.1 Union-Bio science Company Details
  • 11.12.2 Union-Bio science Business Overview
  • 11.12.3 Union-Bio science Oral Voriconazole Introduction
  • 11.12.4 Union-Bio science Revenue in Oral Voriconazole Business (2019-2024)
  • 11.12.5 Union-Bio science Recent Development
• 11.13 Brilliant Pharmaceuticals
  • 11.13.1 Brilliant Pharmaceuticals Company Details
  • 11.13.2 Brilliant Pharmaceuticals Business Overview
  • 11.13.3 Brilliant Pharmaceuticals Oral Voriconazole Introduction
  • 11.13.4 Brilliant Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024)
  • 11.13.5 Brilliant Pharmaceuticals Recent Development
• 11.14 Zhuhai Rundu Pharmaceutical
  • 11.14.1 Zhuhai Rundu Pharmaceutical Company Details
  • 11.14.2 Zhuhai Rundu Pharmaceutical Business Overview
  • 11.14.3 Zhuhai Rundu Pharmaceutical Oral Voriconazole Introduction
  • 11.14.4 Zhuhai Rundu Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024)
  • 11.14.5 Zhuhai Rundu Pharmaceutical Recent Development
• 11.15 Poly Pharm
  • 11.15.1 Poly Pharm Company Details
  • 11.15.2 Poly Pharm Business Overview
  • 11.15.3 Poly Pharm Oral Voriconazole Introduction
  • 11.15.4 Poly Pharm Revenue in Oral Voriconazole Business (2019-2024)
  • 11.15.5 Poly Pharm Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Oral Voriconazole Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Voriconazole Tablets

Table 3. Key Players of Voriconazole Capsules

Table 4. Key Players of Voriconazole Suspension

Table 5. Global Oral Voriconazole Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Oral Voriconazole Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Oral Voriconazole Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Oral Voriconazole Market Share by Region (2019-2024)

Table 9. Global Oral Voriconazole Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Oral Voriconazole Market Share by Region (2025-2030)

Table 11. Oral Voriconazole Market Trends

Table 12. Oral Voriconazole Market Drivers

Table 13. Oral Voriconazole Market Challenges

Table 14. Oral Voriconazole Market Restraints

Table 15. Global Oral Voriconazole Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Oral Voriconazole Market Share by Players (2019-2024)

Table 17. Global Top Oral Voriconazole Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Voriconazole as of 2023)

Table 18. Global Oral Voriconazole Industry Ranking 2022 VS 2023

Table 19. Global 5 Largest Players Market Share by Oral Voriconazole Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Oral Voriconazole, Headquarters and Area Served

Table 21. Global Key Players of Oral Voriconazole, Product and Application

Table 22. Global Key Players of Oral Voriconazole, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Oral Voriconazole Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Oral Voriconazole Revenue Market Share by Type (2019-2024)

Table 26. Global Oral Voriconazole Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Oral Voriconazole Revenue Market Share by Type (2025-2030)

Table 28. Global Oral Voriconazole Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Oral Voriconazole Revenue Market Share by Application (2019-2024)

Table 30. Global Oral Voriconazole Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Oral Voriconazole Revenue Market Share by Application (2025-2030)

Table 32. North America Oral Voriconazole Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Oral Voriconazole Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Oral Voriconazole Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Oral Voriconazole Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Oral Voriconazole Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Oral Voriconazole Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Oral Voriconazole Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Oral Voriconazole Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Oral Voriconazole Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Oral Voriconazole Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Oral Voriconazole Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Oral Voriconazole Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Oral Voriconazole Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Oral Voriconazole Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Oral Voriconazole Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Oral Voriconazole Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Oral Voriconazole Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Oral Voriconazole Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Oral Voriconazole Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Oral Voriconazole Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Oral Voriconazole Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Oral Voriconazole Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Oral Voriconazole Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Oral Voriconazole Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Oral Voriconazole Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Oral Voriconazole Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Oral Voriconazole Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Oral Voriconazole Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Oral Voriconazole Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Oral Voriconazole Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Oral Voriconazole Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Oral Voriconazole Market Size by Country (2025-2030) & (US$ Million)

Table 64. Pfizer Company Details

Table 65. Pfizer Business Overview

Table 66. Pfizer Oral Voriconazole Product

Table 67. Pfizer Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 68. Pfizer Recent Development

Table 69. Sandoz Company Details

Table 70. Sandoz Business Overview

Table 71. Sandoz Oral Voriconazole Product

Table 72. Sandoz Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 73. Sandoz Recent Development

Table 74. Sun Pharmaceutical Company Details

Table 75. Sun Pharmaceutical Business Overview

Table 76. Sun Pharmaceutical Oral Voriconazole Product

Table 77. Sun Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 78. Sun Pharmaceutical Recent Development

Table 79. Teva Company Details

Table 80. Teva Business Overview

Table 81. Teva Oral Voriconazole Product

Table 82. Teva Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 83. Teva Recent Development

Table 84. Taj Pharmaceuticals Company Details

Table 85. Taj Pharmaceuticals Business Overview

Table 86. Taj Pharmaceuticals Oral Voriconazole Product

Table 87. Taj Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 88. Taj Pharmaceuticals Recent Development

Table 89. SiNi Pharma Company Details

Table 90. SiNi Pharma Business Overview

Table 91. SiNi Pharma Oral Voriconazole Product

Table 92. SiNi Pharma Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 93. SiNi Pharma Recent Development

Table 94. Lupin Pharmaceuticals Company Details

Table 95. Lupin Pharmaceuticals Business Overview

Table 96. Lupin Pharmaceuticals Oral Voriconazole Product

Table 97. Lupin Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 98. Lupin Pharmaceuticals Recent Development

Table 99. Viona Pharmaceuticals Company Details

Table 100. Viona Pharmaceuticals Business Overview

Table 101. Viona Pharmaceuticals Oral Voriconazole Product

Table 102. Viona Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 103. Viona Pharmaceuticals Recent Development

Table 104. Yangzijiang Pharmaceutical Group Company Details

Table 105. Yangzijiang Pharmaceutical Group Business Overview

Table 106. Yangzijiang Pharmaceutical Group Oral Voriconazole Product

Table 107. Yangzijiang Pharmaceutical Group Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 108. Yangzijiang Pharmaceutical Group Recent Development

Table 109. Huahai Pharmaceutical Company Details

Table 110. Huahai Pharmaceutical Business Overview

Table 111. Huahai Pharmaceutical Oral Voriconazole Product

Table 112. Huahai Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 113. Huahai Pharmaceutical Recent Development

Table 114. Beijing Genetech Pharmaceutical Company Details

Table 115. Beijing Genetech Pharmaceutical Business Overview

Table 116. Beijing Genetech Pharmaceutical Oral Voriconazole Product

Table 117. Beijing Genetech Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 118. Beijing Genetech Pharmaceutical Recent Development

Table 119. Union-Bio science Company Details

Table 120. Union-Bio science Business Overview

Table 121. Union-Bio science Oral Voriconazole Product

Table 122. Union-Bio science Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 123. Union-Bio science Recent Development

Table 124. Brilliant Pharmaceuticals Company Details

Table 125. Brilliant Pharmaceuticals Business Overview

Table 126. Brilliant Pharmaceuticals Oral Voriconazole Product

Table 127. Brilliant Pharmaceuticals Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 128. Brilliant Pharmaceuticals Recent Development

Table 129. Zhuhai Rundu Pharmaceutical Company Details

Table 130. Zhuhai Rundu Pharmaceutical Business Overview

Table 131. Zhuhai Rundu Pharmaceutical Oral Voriconazole Product

Table 132. Zhuhai Rundu Pharmaceutical Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 133. Zhuhai Rundu Pharmaceutical Recent Development

Table 134. Poly Pharm Company Details

Table 135. Poly Pharm Business Overview

Table 136. Poly Pharm Oral Voriconazole Product

Table 137. Poly Pharm Revenue in Oral Voriconazole Business (2019-2024) & (US$ Million)

Table 138. Poly Pharm Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oral Voriconazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Oral Voriconazole Market Share by Type: 2023 VS 2030

Figure 3. Voriconazole Tablets Features

Figure 4. Voriconazole Capsules Features

Figure 5. Voriconazole Suspension Features

Figure 6. Global Oral Voriconazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Oral Voriconazole Market Share by Application: 2023 VS 2030

Figure 8. Hospital Pharmacy Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Oral Voriconazole Report Years Considered

Figure 11. Global Oral Voriconazole Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Oral Voriconazole Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Oral Voriconazole Market Share by Region: 2023 VS 2030

Figure 14. Global Oral Voriconazole Market Share by Players in 2023

Figure 15. Global Top Oral Voriconazole Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Voriconazole as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Oral Voriconazole Revenue in 2023

Figure 17. North America Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Oral Voriconazole Market Share by Type (2019-2030)

Figure 19. North America Oral Voriconazole Market Share by Application (2019-2030)

Figure 20. North America Oral Voriconazole Market Share by Country (2019-2030)

Figure 21. United States Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Oral Voriconazole Market Share by Type (2019-2030)

Figure 25. Europe Oral Voriconazole Market Share by Application (2019-2030)

Figure 26. Europe Oral Voriconazole Market Share by Country (2019-2030)

Figure 27. Germany Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Oral Voriconazole Market Share by Type (2019-2030)

Figure 35. China Oral Voriconazole Market Share by Application (2019-2030)

Figure 36. Asia Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Asia Oral Voriconazole Market Share by Type (2019-2030)

Figure 38. Asia Oral Voriconazole Market Share by Application (2019-2030)

Figure 39. Asia Oral Voriconazole Market Share by Region (2019-2030)

Figure 40. Japan Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Oral Voriconazole Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Oral Voriconazole Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Oral Voriconazole Market Share by Country (2019-2030)

Figure 50. Brazil Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Oral Voriconazole Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Pfizer Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 57. Sandoz Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 58. Sun Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 59. Teva Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 60. Taj Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 61. SiNi Pharma Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 62. Lupin Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 63. Viona Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 64. Yangzijiang Pharmaceutical Group Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 65. Huahai Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 66. Beijing Genetech Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 67. Union-Bio science Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 68. Brilliant Pharmaceuticals Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 69. Zhuhai Rundu Pharmaceutical Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 70. Poly Pharm Revenue Growth Rate in Oral Voriconazole Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed